GreenlightPA Contact
✨ New — Drug Recommender

Which drug will get approved for your patient?

The standard PA checker starts with a drug. This tool starts with your patient. Enter their age, insurer, disease extent, and what topical therapies they've already tried — and we'll rank Dupixent and Adbry by likelihood of approval across Aetna, Cigna, and UnitedHealthcare.

Age matters. Adbry requires age ≥12. Dupixent is approved from 6 months.
Step therapy varies. UHC requires 2 topical classes; Aetna and Cigna require 1.
Aetna bypass. Prior biologic use in the past year skips step therapy entirely.

No PHI. No login. Based on published insurer policies, March 2026. Currently covers atopic dermatitis only.

Disease extent
Prior systemic therapy

e.g. previously tried Dupixent or a JAK inhibitor — triggers Aetna's bypass pathway and skips step therapy

Topical therapies already tried (check all that apply)

Help improve GreenlightPA — did this recommendation match what actually happened?

Thank you — your feedback helps us improve accuracy for everyone.

No patient data is collected. Your response is anonymous and tied only to the insurer and drug combination shown above.

How the recommender works

Based on published insurer policies

Every rule used in the recommender comes directly from Aetna, Cigna, and UnitedHealthcare's prior authorization policy documents. Sources are cited and dated.

Ranked by approval likelihood

Results are ordered by how many criteria your patient already meets, step therapy burden remaining, and practical factors like authorization duration.

No PHI, no login

All logic runs in your browser. No patient data leaves your device. No account required.

Improving with real-world outcomes

When you let us know whether a recommendation matched the actual approval decision, we use that signal — anonymously — to improve future accuracy.

Disclaimer: This tool is for informational purposes only and does not constitute medical, legal, or insurance advice. Prior authorization criteria vary by plan and may change without notice. Always verify requirements with official payer policy documents before making clinical or administrative decisions.